All

× UPDATE! Updated as of 30 September 2024.
Records 281 to 300 of 34750
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-906_PI_01.pdf BR-906 Golimumab Simponi 50 mg/0.5 mL Solution For Injection (SC) Prescription Drug (RX) - Baxter Pharmaceutical Solutions LLC United States of America Initial 15 March 2022 14 May 2026
View BR-909 Enoxaparin Sodium Enoclex 60mg/0.6mL Solution For Injection (SC) Prescription Drug (Rx) Antithrombotic Agent Shenzhen Techdow Pharmaceutical Co., Ltd. China Automatic Renewal 14 April 2023 21 May 2028
View BR-911 LIVE ATTENUATED MEASLES, MUMPS and RUBELLA VACCINE NONE 10 Dose Freeze- Dried Powder For Injection ( S.C ) Prescription Drug (Rx) VACCINE Serum Institute of India Ltd. India Renewal 21 March 2023 21 May 2028
View BR-916 Choriogonadotropin Alfa Ovidrel 250 mcg/0.5 mL Solution for Injection (SC) Prescription Drug (RX) - Merck Serono S.p.A. Italy Renewal 31 March 2023 23 July 2028
View BR-917 Measles, Mumps and Rubella Vaccine (Live, Attenuated) M-M-R II REMARKS: Formulation: After reconstitution, each dose (0.5 mL) contains: Live, attenuated virus derived from Edmonston B strain of measles………………… 3.0 log TCID50* Live, attenuated Jeryl Lynn strain of mumps…………..4.1 log TCID50* Live, attenuated Wistar RA27/3 strain of rubella. …………3.0 log TCID50* *TCID 50 - Tissue Culture Infectivity Dose 50% Lyophilized Powder for Solution for Injection (IM/SC) Prescription Drug (RX) - Merck Sharp and Dohme LLC U.S.A Renewal 26 April 2023 26 January 2028
View BR-918 Clostridium Botulinum Toxin Type A HugelTox 100 Units Lyophilized Powder For Injection Prescription Drug (RX) Muscle Relaxant Hugel, Inc. Korea Renewal 22 March 2023 07 August 2028
View BR-919 Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) Hexaxim Formulation: Each dose (0.5 mL) contains: Diphtheria toxoid' Tetanus toxoid ' Bordetella pertussis antigen Pertussis toxoid' Filamentous hemagglutinin' Poliovirus (Inactivated)2.3 Type I (Mahoney) strain NLT 20 IU NLT 40 IU Hepatitis B surface antigen Haemophilus influenzae Type B Polysaccharide Phosphate) 10 mcg (Polyribosylribitol 12 mcg Conjugate to Tetanus protein 22-36 mcg 25 mcg 25 mcg 40 D antigen units Type II (MEF-1) strain" Type III (Saukett) strain1 8 D antigen units 32 D antigen units 'adsorbed on aluminium hydroxide, hydrated (Al(OH)3) 2produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 3adsorbed on aluminium phosphate (AIPO4) *propagated in VERO cells Suspension for Injection (IM) Prescription Drug (RX) Vaccines Sanofi Pasteur France Renewal 04 September 2023 29 August 2028
View BR-920 Filgrastim (Recombinant Human Granulocyte Colony Stimulating Factor) White-C 300 mcg/mL Solution For Injection Prescription Drug (RX) Hematopoietic Growth Factor Shandong Kexing Bioproducts Co., Ltd. China Renewal 27 December 2018 03 September 2028
View BR-921 Human Rabie Immunoglobulin H-Ryg 100IU/mL Solution For Injection (IM) Prescription Drug (RX) Immunoglobulin Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. China Automatic Renewal 07 January 2022 03 September 2026
View BR-922 Human Tetanus Immunoglobulin H-Tyg 100IU/mL Solution For Injection (IM) Prescription Drug (RX) Immunoglobulins Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. China Automatic Renewal 07 January 2022 03 September 2026
View BR-923 Japanese Encephalitis Vaccine (Live, Attenuated) Imojev Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus. Powder for Suspension for Injection (SC) Prescription Drug (RX) - Government Pharmaceutical Organization - Merieux Biological Products Co., Ltd. Thailand Initial (Variation) 13 July 2022 13 July 2027
View BR-925 Human Papillomavirus Vaccine [Types 16 and 18] (Recombinant, adjuvanted, adsorbed) Cervarix Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 L1 protein*. Human Papillomavirus type 18 L1 protein*. .20 mcg ...... 20 mcg *adjuvanted by AS04 containing 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3] Suspension for Injection (IM) Prescription Drug (RX) Vaccine GlaxoSmithKline Biologicals SA Belgium Renewal (Reconstruction) 22 February 2024 23 March 2027
View BR-929 Poliomyelitis Vaccine (Type 1, 2 and 3) (Inactivated) Imovax Polio Formulation: Each dose (0.5 mL) contains: Poliovirus type 1, Mahoney strain (inactivated)....... 40 D antigen units Poliovirus type 2, MEF-1 strain (inactivated)........... 8 D antigen units Poliovirus type 3, Saukett strain (inactivated)............32 D antigen units Suspension for Injection (IM/SC) Prescription Drug (RX) Vaccines Sanofi Pasteur France Renewal 03 January 2024 31 October 2028
View BR-938 Epoetin alfa Renogen 2000 IU/mL Solution for Injection (IV/SC) Prescription Drug (RX) Antianemic Preparations Intas Biopharmaceuticals Ltd. India Renewal 12 January 2024 18 March 2029
View BR-939 Enoxaparin Sodium Enoclex 40 mg/0.4 mL Solution For Injection (S.C.) Prescription Drug (RX) Antithrombotic Agent Shenzhen Techdow Pharmaceutical Co., Ltd. China Renewal 24 October 2023 14 April 2029
View BR-940 Epoetin alfa (Recombinant Human Erythropoietin) Renogen 4,000 IU/mL Solution for Injection (IV/SC) Prescription Drug (RX) Hematopoietic Growth Factor Intas Biopharmaceuticals Ltd. India Automatic Renewal (E-AR) 05 January 2024 14 April 2029
View BR-948 Insulin Human (rDNA) Humulin N Kwikpen 100 IU/mL Suspension For Injection (S.C.) Prescription Drug (RX) Antidiabetics Lilly France(Fegersheim) France Renewal 19 January 2024 27 May 2029
View BR-950 Insulin Human (rDNA) Humulin 70/30 Kwikpen 100 IU/mL Suspension For Injection (S.C.) Prescription Drug (RX) Antidiabetics Lilly France(Fegersheim) France Renewal 24 January 2024 27 May 2029
View BR-952 Trastuzumab Emtansine Kadcyla 160 mg Powder For Conc. For Sol'N For Iv Infusion Prescription Drug (Rx) Monoclonal Antibody F. Hoffmann-La Roche AG Switzerland Renewal 10 May 2024 30 June 2029
View BR-953 Trastuzumab Emtansine Kadcyla 100 mg Powder For Concentrate For Solution For I.V. Infusion Prescription Drug (RX) Monoclonal Antibody F. Hoffmann-La Roche AG Switzerland Renewal 06 May 2024 30 June 2029